3628 results for «2256»
3628 results
First-in-human studies in cardiovascular devices: from first 10 patients to global innovation — How efficient early studies advance emerging technologies
20 May 2026 – From EuroPCR 2026
Understand the pivotal role of first-in-human studies in advancing cardiovascular device innovation through operational insights from early patient experiences. This session reviews cutting-edge technologies including percutaneous left ventricular assist devices, transcatheter leaflet augmentation, physiology-guided PCI, synchronized diaphragmatic stimulation, pulmonary artery denervation, and perspectives on translating early...
Optimal use of dedicated device for calcified lesions
20 May 2026 – From EuroPCR 2026
This session delves into the optimal utilization of dedicated devices for managing complex coronary calcification. Explore decision-making strategies involving orbital atherectomy and cutting balloon techniques, as well as advanced approaches like contact intravascular lithotripsy for stented calcified nodules. Additional focus is given to ablative and modifying...
PFO closure - Progression in practice
20 May 2026 – From EuroPCR 2026
This session presents progressive insights into patent foramen ovale (PFO) closure, comparing outcomes across age groups and evaluating residual shunting via transcranial Doppler. It highlights tailored antiplatelet therapy durations from the PROLONG registry, long-term safety and efficacy data, morphological variations of the fossa ovalis, and the...
Mitral paravalvular leak closure: case-bases strategies
20 May 2026 – From EuroPCR 2026
This session presents case-based strategies for mitral paravalvular leak closure, highlighting complex percutaneous approaches including multivalvular failure management, apical access techniques, and transatrial direct surgical valve-in-MAC procedures. It features challenging clinical scenarios demonstrating innovative solutions for hemolytic leaks and complex paravalvular defects.
Align for the future with structural heart innovations - LIVE case and major trial updates
19 May 2026 – From EuroPCR 2026
Stay abreast of structural heart innovations with expert discussions on best-in-class transcatheter aortic valve implantation (TAVI) practices, including imaging, sizing, and procedural strategies. This session with LIVE case introduces the novel Myval Octapro+ transcatheter heart valve (THV), its design philosophy, and potential clinical benefits, along with...
Breaking the calcium challenge: the power of Hertz with LithiX intravascular lithotripsy
20 May 2026 – From EuroPCR 2026
Calcified coronary lesions remain a major challenge in PCI, particularly when lesion rigidity limits device delivery and optimal stent expansion.
This EuroPCR 2026 session focuses on contemporary calcium modification strategies and the role of the Hertz contact intravascular lithotripsy (HC-IVL) system in simplifying treatment of complex calcified...
Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes
20 May 2026 – From EuroPCR 2026
This session explores how to optimise left main PCI through the integration of intracoronary imaging and physiology using Ultreon 3.0 software. It highlights how this innovative technology supports decision-making, procedural planning, and stent optimisation to improve outcomes in complex lesion management.
High definition IVUS-guided treatment strategies in calcified stenoses
20 May 2026 – From EuroPCR 2026
Severely calcified coronary stenoses remain one of the most challenging subsets in contemporary PCI, requiring precise lesion assessment and tailored treatment strategies.
This EuroPCR 2026 session focuses on how high-definition intravascular ultrasound (IVUS) is changing the way these lesions are approached in daily practice.
HD-IVUS enables detailed detection...
Evidence in action: advancing care for angina with Shockwave Reducer
20 May 2026 – From EuroPCR 2026
Despite major advances in coronary revascularisation and medical therapy, angina continues to represent a significant clinical burden, affecting both quality of life and long-term patient management.
This EuroPCR 2026 session explores the emerging role of the Shockwave Reducer as a therapeutic option in patients with persistent angina....
DK Score Pro in focus: innovation, evidence, and everyday practice
20 May 2026 – From EuroPCR 2026
Watch this EuroPCR 2026 session to better understand how lesion preparation strategies can be optimised in complex PCI using directional scoring balloon technology with DK Score Pro.
Clinical evidence is reviewed, including insights from the SCORE CHINA registry, alongside practical considerations for integrating this approach into routine...
Expanding the horizon - Trials addressing unchartered territories in coronary and structural heart
20 May 2026 – From EuroPCR 2026
New clinical evidence is pushing coronary and structural heart therapy into areas that were previously uncertain or inconsistently defined, with multiple landmark trials now shaping future practice.
Among the studies discussed in this EuroPCR 2026 session, are SORT OUT XII, START YOUNG, BISCUSPID, LANDMARK 2 and RESTORE...
Beyond the horizon - Future of structural heart innovations and PCI
20 May 2026 – From EuroPCR 2026
Structural heart and coronary interventions are expanding rapidly, with innovation increasingly focused on managing complex anatomies and diversifying treatment strategies.
The PRISM-PCI toolkit is introduced as a framework to support decision-making in complex PCI, alongside advances in transcatheter valve therapies spanning mitral, tricuspid and pulmonary interventions, as...
Novelties in epicardial physiology: PPG explained in a simulated environment
20 May 2026 – From EuroPCR 2026
Understanding coronary physiology continues to evolve as new indices aim to refine how epicardial disease is assessed in daily practice.
The perfusion pressure gradient (PPG) index is introduced in this EuroPCR 2026 session as a novel approach to characterising epicardial coronary physiology. Rather than relying solely on...
Advancing mitral transcatheter edge-to-edge repair in complex lesions
20 May 2026 – From EuroPCR 2026
Learn how advanced imaging, careful anatomical assessment and tailored procedural strategies are helping expand the possibilities of mitral transcatheter edge-to-edge repair (M-TEER) in complex lesions.
Focusing on atrial secondary mitral regurgitation (SMR) and commissural mitral regurgitation, this EuroPCR 2026 session reviews evidence, showing that M-TEER can be...
Seeing differently, treating better: advanced imaging shaping modern structural heart practice
20 May 2026 – From EuroPCR 2026
This session explores the transformative role of advanced imaging, particularly 3D intracardiac echocardiography (ICE), in modern structural heart interventions. It provides practical insights into implementation, highlighting how these tools can enhance workflow efficiency and procedural confidence across transcatheter edge-to-edge repair (TEER), left atrial appendage (LAA) closure,...
From access to reperfusion: a procedural deep dive into pulmonary embolism
20 May 2026 – From EuroPCR 2026
From vascular access to reperfusion strategy, managing acute pulmonary embolism requires rapid decision-making, careful patient selection and increasingly sophisticated interventional techniques.
This EuroPCR 2026 session takes a procedural deep dive into contemporary pulmonary embolism management, focusing on thrombus aspiration techniques and the evolving role of computer-assisted vacuum...
PRISM-PCI - From clarity to cure
20 May 2026 – From EuroPCR 2026
PRISM-PCI offers cutting-edge imaging innovations and treatment strategies aimed at optimizing complex PCI procedures. This session explores the 'leave nothing behind' concept with thin-strut bioresorbable scaffolds and sirolimus drug-coated balloons, updates on ultra thin-strut DES platforms, including the SORT OUT XII trial, and introduces a comprehensive...
The continuum of valvular heart disease: a lifetime management approach
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...
Navigating high-thrombus burden in ACS: precision aspiration thrombectomy with CAT RX
21 May 2026 – From EuroPCR 2026
This session explores the challenges of managing high thrombus burden in patients with acute coronary syndromes (ACS), with a focus on precision aspiration thrombectomy using the CAT RX device. Through case-based examples, it provides practical insights into procedural techniques and examines the role of CAT RX...
Real world practice inspiring new evidence generation in structural heart
21 May 2026 – From EuroPCR 2026
This LIVE case session showcases real-world clinical practice driving new evidence in structural heart interventions, with a focus on TAVI. It features expert insights into pre-procedural imaging and sizing, treatment strategies, procedural techniques, and post-procedural management. The session also introduces the novel Myval Octapro+ transcatheter heart...
